This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2010 Feb 25;362(8):717-25.

doi: 10.1056/NEJMct0910329.

Permethrin and ivermectin for scabies

Bart J Currie¹, James S McCarthy

Affiliations

PMID: 20181973
DOI: 10.1056/NEJMct0910329

Review

Permethrin and ivermectin for scabies

Bart J Currie et al. N Engl J Med. 2010.

. 2010 Feb 25;362(8):717-25.

doi: 10.1056/NEJMct0910329.

Authors

Bart J Currie¹, James S McCarthy

Affiliation

¹ Menzies School of Health Research, Royal Darwin Hospital, Darwin, NT, Australia. bart@menzies.edu.au

PMID: 20181973
DOI: 10.1056/NEJMct0910329

No abstract available

PubMed Disclaimer

Similar articles

Treatment of scabies: Comparison of permethrin 5% versus ivermectin.
Goldust M, Rezaee E, Hemayat S. Goldust M, et al. J Dermatol. 2012 Jun;39(6):545-7. doi: 10.1111/j.1346-8138.2011.01481.x. Epub 2012 Mar 5. J Dermatol. 2012. PMID: 22385121 Clinical Trial.
Clinical practices. Scabies.
Chosidow O. Chosidow O. N Engl J Med. 2006 Apr 20;354(16):1718-27. doi: 10.1056/NEJMcp052784. N Engl J Med. 2006. PMID: 16625010 Review. No abstract available.
[Scabies].
Ohtaki N. Ohtaki N. Nihon Rinsho. 2003 Feb;61 Suppl 2:649-53. Nihon Rinsho. 2003. PMID: 12722296 Review. Japanese. No abstract available.
Clinical inquiries. When should you treat scabies empirically?
Page TL, Eiff MP, Judkins DZ, Walker B. Page TL, et al. J Fam Pract. 2007 Jul;56(7):570-2. J Fam Pract. 2007. PMID: 17605950 Review. No abstract available.
Mass Drug Administration for Scabies Control in a Population with Endemic Disease.
Romani L, Whitfeld MJ, Koroivueta J, Kama M, Wand H, Tikoduadua L, Tuicakau M, Koroi A, Andrews R, Kaldor JM, Steer AC. Romani L, et al. N Engl J Med. 2015 Dec 10;373(24):2305-13. doi: 10.1056/NEJMoa1500987. N Engl J Med. 2015. PMID: 26650152 Clinical Trial.

See all similar articles

Cited by

A Boy with an Itch: A Case Report of Genital Nodular Scabies.
Bruno TF, Seo DJ. Bruno TF, et al. Glob Pediatr Health. 2024 Nov 20;11:2333794X241295986. doi: 10.1177/2333794X241295986. eCollection 2024. Glob Pediatr Health. 2024. PMID: 39575310 Free PMC article.
Evaluating the quality and reliability of YouTube videos on scabies in children: A cross-sectional study.
Ozdemir Kacer E, Kacer I. Ozdemir Kacer E, et al. PLoS One. 2024 Oct 17;19(10):e0310508. doi: 10.1371/journal.pone.0310508. eCollection 2024. PLoS One. 2024. PMID: 39418293 Free PMC article.
Scabies.
Fernando DD, Mounsey KE, Bernigaud C, Surve N, Estrada Chávez GE, Hay RJ, Currie BJ, Chosidow O, Fischer K. Fernando DD, et al. Nat Rev Dis Primers. 2024 Oct 3;10(1):74. doi: 10.1038/s41572-024-00552-8. Nat Rev Dis Primers. 2024. PMID: 39362885 Review.
One versus two doses of ivermectin-based mass drug administration for the control of scabies: A cluster randomised non-inferiority trial.
Lake SJ, Engelman D, Zinihite J, Sokana O, Boara D, Nasi T, Gorae C, Osti MH, Phelan S, Parnaby M, Grobler AC, Schuster T, Andrews R, Whitfeld MJ, Marks M, Romani L, Steer AC, Kaldor JM. Lake SJ, et al. PLoS Negl Trop Dis. 2023 Mar 17;17(3):e0011207. doi: 10.1371/journal.pntd.0011207. eCollection 2023 Mar. PLoS Negl Trop Dis. 2023. PMID: 36930667 Free PMC article. Clinical Trial.
Pharmacokinetic and pharmacodynamic considerations for treating sarcoptic mange with cross-relevance to Australian wildlife.
Takano K, de Hayr L, Carver S, Harvey RJ, Mounsey KE. Takano K, et al. Int J Parasitol Drugs Drug Resist. 2023 Apr;21:97-113. doi: 10.1016/j.ijpddr.2023.02.004. Epub 2023 Mar 5. Int J Parasitol Drugs Drug Resist. 2023. PMID: 36906936 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information